ENTRY       D10463                      Drug
NAME        Ripasudil hydrochloride hydrate (JAN);
            Glanatec (TN)
FORMULA     C15H18FN3O2S. HCl. 2H2O
EXACT_MASS  395.1082
MOL_WEIGHT  395.8772
CLASS       Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      Therapeutic category: 1319
            ATC code: S01EX07
            Product: D10463<JP>
            Product (mixture): D12437<JP>
EFFICACY    Antiglaucoma, Rho-associated kinase inhibitor
TARGET      ROCK [HSA:6093 9475] [KO:K04514 K17388]
  PATHWAY   hsa04270(6093+9475)  Vascular smooth muscle contraction
            hsa04670(6093+9475)  Leukocyte transendothelial migration
            hsa04810(6093+9475)  Regulation of actin cytoskeleton
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EX Other antiglaucoma preparations
                 S01EX07 Ripasudil
                  D10463  Ripasudil hydrochloride hydrate (JAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D10463  Ripasudil hydrochloride hydrate (JAN)
            Drug groups [BR:br08330]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D10463  Ripasudil hydrochloride hydrate
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D10463  Ripasudil hydrochloride hydrate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               AGC group
                ROCK
                 D10463  Ripasudil hydrochloride hydrate (JAN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10463
DBLINKS     PubChem: 172232556
ATOM        25
            1   C1x C    18.9000  -15.4700
            2   C1x C    18.0600  -14.3500
            3   C1x C    18.3400  -12.9500
            4   N1x N    19.6700  -12.3900
            5   N1y N    20.3000  -15.4700
            6   C1x C    20.8600  -13.0200
            7   C1y C    21.2100  -14.3500
            8   S4a S    20.3000  -16.8700
            9   C8y C    20.3000  -18.2700
            10  O3c O    21.7000  -16.8700
            11  O3c O    18.9000  -16.8700
            12  C8x C    19.1100  -18.9700
            13  C8x C    19.1100  -20.3700
            14  C8x C    20.3000  -21.0700
            15  C8y C    21.4900  -20.3700
            16  C8y C    21.4900  -18.9700
            17  C8x C    22.7500  -21.0700
            18  N5x N    23.9400  -20.3700
            19  C8x C    23.9400  -18.9700
            20  C8y C    22.7500  -18.2700
            21  C1a C    22.5785  -14.6453
            22  X   F    22.7672  -16.8701
            23  X   Cl   26.2500  -16.5900
            24  O0  O    26.7400  -18.3400
            25  O0  O    26.7400  -19.6700
BOND        24
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     5   8 1
            9     8   9 1
            10    8  10 2
            11    8  11 2
            12    9  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17    9  16 1
            18   15  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   16  20 1
            23    7  21 1 #Down
            24   20  22 1
///
